HealthcareGlobal
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
May 19 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES - LAUNCHES CANCER HOSPITAL WITH UP TO 132 BEDS IN HEBBAL, BENGALURU
Source text: ID:nBSE4ngg11
Further company coverage: HEAC.NS
(([email protected];))
May 19 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES - LAUNCHES CANCER HOSPITAL WITH UP TO 132 BEDS IN HEBBAL, BENGALURU
Source text: ID:nBSE4ngg11
Further company coverage: HEAC.NS
(([email protected];))
Feb 24 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
RIGHTS ISSUE UP TO 4.25 BILLION RUPEES APPROVED
RIGHTS ISSUE PRICE AT 512 RUPEES/SHARE, RATIO IS 1 SHARE FOR EVERY 17 SHARES
Source text: ID:nBSE4jylYH
Further company coverage: HEAC.NS
(([email protected];;))
Feb 24 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
RIGHTS ISSUE UP TO 4.25 BILLION RUPEES APPROVED
RIGHTS ISSUE PRICE AT 512 RUPEES/SHARE, RATIO IS 1 SHARE FOR EVERY 17 SHARES
Source text: ID:nBSE4jylYH
Further company coverage: HEAC.NS
(([email protected];;))
Feb 17 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES LTD - APPROVES EQUITY SHARES ISSUANCE FOR 4.25 BILLION RUPEES
HEALTHCARE GLOBAL ENTERPRISES LTD - ISSUANCE OF EQUITY SHARES VIA RIGHTS ISSUE
Source text: ID:nBSE3c7jHs
Further company coverage: HEAC.NS
(([email protected];;))
Feb 17 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES LTD - APPROVES EQUITY SHARES ISSUANCE FOR 4.25 BILLION RUPEES
HEALTHCARE GLOBAL ENTERPRISES LTD - ISSUANCE OF EQUITY SHARES VIA RIGHTS ISSUE
Source text: ID:nBSE3c7jHs
Further company coverage: HEAC.NS
(([email protected];;))
** Investment by U.S. private equity firm KKR KKR.N to acquire controlling stake in Healthcare Global Enterprises HEAC.NS will bring in more operational, financial efficiency, PL Capital says
** Brokerage raises HEAC's PT to 555 rupees from 535 rupees, maintains "buy" rating
** Expects KKR to drive growth in the cancer care provider through bed expansion, assets' rationalization, margins expansion
** Co's asset-light approach with focus on partnerships has made its model more capital efficient, scalable, PL Capital says
** Stock last down 1.5% amid broader market rout
(Reporting by Aleef Jahan in Bengaluru)
** Investment by U.S. private equity firm KKR KKR.N to acquire controlling stake in Healthcare Global Enterprises HEAC.NS will bring in more operational, financial efficiency, PL Capital says
** Brokerage raises HEAC's PT to 555 rupees from 535 rupees, maintains "buy" rating
** Expects KKR to drive growth in the cancer care provider through bed expansion, assets' rationalization, margins expansion
** Co's asset-light approach with focus on partnerships has made its model more capital efficient, scalable, PL Capital says
** Stock last down 1.5% amid broader market rout
(Reporting by Aleef Jahan in Bengaluru)
** Shares of Healthcare Global Enterprises HEAC.NS rise 3.5% to 517 rupees
** The healthcare services provider said U.S. private equity firm KKR to acquire controlling stake in co for $400 million
** KKR will initially acquire a 51% stake in HEAC, with an option to purchase an additional 3% if its open offer for a further 26% stake is unsuccessful
** More than 374,000 shares change hands, 1.3x its 30-day avg
** Five analysts covering the stock on avg have a "buy" rating; median PT is 546 rupees - LSEG data
** Healthcare Global stock has gained 4% so far this year
(Reporting by Ashna Teresa Britto in Bengaluru)
(([email protected] ; ( +91 8078332441))
** Shares of Healthcare Global Enterprises HEAC.NS rise 3.5% to 517 rupees
** The healthcare services provider said U.S. private equity firm KKR to acquire controlling stake in co for $400 million
** KKR will initially acquire a 51% stake in HEAC, with an option to purchase an additional 3% if its open offer for a further 26% stake is unsuccessful
** More than 374,000 shares change hands, 1.3x its 30-day avg
** Five analysts covering the stock on avg have a "buy" rating; median PT is 546 rupees - LSEG data
** Healthcare Global stock has gained 4% so far this year
(Reporting by Ashna Teresa Britto in Bengaluru)
(([email protected] ; ( +91 8078332441))
-- Source link: https://tinyurl.com/bdz39327
-- Note: Reuters has not verified this story and does not vouch for its accuracy
((Bengaluru newsroom, [email protected]))
-- Source link: https://tinyurl.com/bdz39327
-- Note: Reuters has not verified this story and does not vouch for its accuracy
((Bengaluru newsroom, [email protected]))
July 2 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES- ACQUISITION OF SHARES OF VIZAG HOSPITAL AND CANCER RESEARCH CENTRE
HEALTHCARE GLOBAL ENTERPRISES LTD- COST OF ACQUISITION OF 51% STAKE AT 2.08 BILLION RUPEES
HEALTHCARE GLOBAL ENTERPRISES- COST OF ACQUISITION OF ADDITIONAL 34% STAKE AT 1.55 BILLION RUPEES
Source text for Eikon: ID:nBSE4bgLbx
Further company coverage: HEAC.NS
(([email protected];))
July 2 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES- ACQUISITION OF SHARES OF VIZAG HOSPITAL AND CANCER RESEARCH CENTRE
HEALTHCARE GLOBAL ENTERPRISES LTD- COST OF ACQUISITION OF 51% STAKE AT 2.08 BILLION RUPEES
HEALTHCARE GLOBAL ENTERPRISES- COST OF ACQUISITION OF ADDITIONAL 34% STAKE AT 1.55 BILLION RUPEES
Source text for Eikon: ID:nBSE4bgLbx
Further company coverage: HEAC.NS
(([email protected];))
June 28 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES LTD -ENTERED INTO AGREEMENT WITH VIZAG HOSPITAL
HEALTHCARE GLOBAL ENTERPRISES - CO HAS AGREED UNDER PROVISIONS OF SPA TO ACQUIRE 51% OF EQUITY SHARE CAPITAL IN VIZAG HOSPITAL
HEALTHCARE GLOBAL ENTERPRISES LTD - CO WILL ACQUIRE BALANCE 49% STAKE IN VIZAG HOSPITAL IN TRANCHES
HEALTHCARE GLOBAL ENTERPRISES - COST OF ACQUISITION OF 51% OF EQUITY SHARE CAPITAL OF VIZAG HOSPITAL AT 2.08 BLN RUPEES
HEALTHCARE GLOBAL ENTERPRISES - COST OF ACQUISITION OF ADDITIONAL 34% OF EQUITY SHARE CAPITAL OF VIZAG HOSPITAL AT 1.56 BLN RUPEES
Source text for Eikon: [ID:]
Further company coverage: HEAC.NS
(([email protected];))
June 28 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES LTD -ENTERED INTO AGREEMENT WITH VIZAG HOSPITAL
HEALTHCARE GLOBAL ENTERPRISES - CO HAS AGREED UNDER PROVISIONS OF SPA TO ACQUIRE 51% OF EQUITY SHARE CAPITAL IN VIZAG HOSPITAL
HEALTHCARE GLOBAL ENTERPRISES LTD - CO WILL ACQUIRE BALANCE 49% STAKE IN VIZAG HOSPITAL IN TRANCHES
HEALTHCARE GLOBAL ENTERPRISES - COST OF ACQUISITION OF 51% OF EQUITY SHARE CAPITAL OF VIZAG HOSPITAL AT 2.08 BLN RUPEES
HEALTHCARE GLOBAL ENTERPRISES - COST OF ACQUISITION OF ADDITIONAL 34% OF EQUITY SHARE CAPITAL OF VIZAG HOSPITAL AT 1.56 BLN RUPEES
Source text for Eikon: [ID:]
Further company coverage: HEAC.NS
(([email protected];))
-- Source link: https://bit.ly/3I0Bjz3
-- Note: Reuters has not verified this story and does not vouch for its accuracy
((Bengaluru newsroom, [email protected]))
-- Source link: https://bit.ly/3I0Bjz3
-- Note: Reuters has not verified this story and does not vouch for its accuracy
((Bengaluru newsroom, [email protected]))
Nov 9 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
INDIA'S HEALTHCARE GLOBAL ENTERPRISES SEPT-QUARTER CONSOL NET PROFIT 135.7 MILLION RUPEES VERSUS 73.8 MILLION RUPEES
HEALTHCARE GLOBAL ENTERPRISES SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 4.86 BILLION RUPEES VERSUS 4.19 BILLION RUPEES
Source text for Eikon: ID:nBSEbngsxM
Further company coverage: HEAC.NS
(([email protected];))
Nov 9 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
INDIA'S HEALTHCARE GLOBAL ENTERPRISES SEPT-QUARTER CONSOL NET PROFIT 135.7 MILLION RUPEES VERSUS 73.8 MILLION RUPEES
HEALTHCARE GLOBAL ENTERPRISES SEPT-QUARTER CONSOL REVENUE FROM OPERATIONS 4.86 BILLION RUPEES VERSUS 4.19 BILLION RUPEES
Source text for Eikon: ID:nBSEbngsxM
Further company coverage: HEAC.NS
(([email protected];))
Nov 8 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES LTD - DECIDED NOT TO PURSUE BTA ARRANGEMENT WITH RADIANT HOSPITAL SERVICES
HEALTHCARE GLOBAL ENTERPRISES LTD - CO EXPLORING OTHER FEASIBLE OPTIONS, FOR OPERATING CANCER CENTRE IN SAMBALPUR
Source text for Eikon: ID:nNSEbLYGCL
Further company coverage: HEAC.NS
(([email protected];))
Nov 8 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES LTD - DECIDED NOT TO PURSUE BTA ARRANGEMENT WITH RADIANT HOSPITAL SERVICES
HEALTHCARE GLOBAL ENTERPRISES LTD - CO EXPLORING OTHER FEASIBLE OPTIONS, FOR OPERATING CANCER CENTRE IN SAMBALPUR
Source text for Eikon: ID:nNSEbLYGCL
Further company coverage: HEAC.NS
(([email protected];))
BENGALURU, Sept 26 (Reuters) - Private equity firm CVC Capital Partners is considering to sell 60.4% stake in Indian cancer hospital chain HealthCare Global Enterprises HEAC.NS, Bloomberg News reported on Tuesday, citing people familiar with the matter.
(Reporting by Kashish Tandon in Bengaluru; Editing by Shinjini Ganguli)
(([email protected];))
BENGALURU, Sept 26 (Reuters) - Private equity firm CVC Capital Partners is considering to sell 60.4% stake in Indian cancer hospital chain HealthCare Global Enterprises HEAC.NS, Bloomberg News reported on Tuesday, citing people familiar with the matter.
(Reporting by Kashish Tandon in Bengaluru; Editing by Shinjini Ganguli)
(([email protected];))
Aug 18 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
SRINIVASA V. RAGHAVAN WILL CEASE TO BE CFO EFFECTIVE AUG 20
NAMES RUBY RITOLIA AS CFO
Source text for Eikon: ID:nNSE7551bL
Further company coverage: HEAC.NS
(([email protected];))
Aug 18 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
SRINIVASA V. RAGHAVAN WILL CEASE TO BE CFO EFFECTIVE AUG 20
NAMES RUBY RITOLIA AS CFO
Source text for Eikon: ID:nNSE7551bL
Further company coverage: HEAC.NS
(([email protected];))
July 18 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES LTD - NAGPUR CANCER HOSPITAL & RESEARCH INSTITUTE, CO AND HCG NCHRI LLP ENTERED INTO A PARTNERSHIP TRANSFER AGREEMENT
Source text for Eikon: ID:nBSE1mMJC5
Further company coverage: HEAC.NS
(([email protected];))
July 18 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
HEALTHCARE GLOBAL ENTERPRISES LTD - NAGPUR CANCER HOSPITAL & RESEARCH INSTITUTE, CO AND HCG NCHRI LLP ENTERED INTO A PARTNERSHIP TRANSFER AGREEMENT
Source text for Eikon: ID:nBSE1mMJC5
Further company coverage: HEAC.NS
(([email protected];))
July 6 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
CO ENTERED INTO SHARE PURCHASE AGREEMENT WITH SHAREHOLDERS OF NCHRI FOR ACQUIRING ENTIRE STAKE IN NCHRI
COST OF ACQUISITION OF ENTIRE SHARES IN NCHRI WOULD BE 141 MILLION RUPEES
Source text for Eikon: ID:nNSE8nKZ5V
Further company coverage: HEAC.NS
(([email protected];;))
July 6 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
CO ENTERED INTO SHARE PURCHASE AGREEMENT WITH SHAREHOLDERS OF NCHRI FOR ACQUIRING ENTIRE STAKE IN NCHRI
COST OF ACQUISITION OF ENTIRE SHARES IN NCHRI WOULD BE 141 MILLION RUPEES
Source text for Eikon: ID:nNSE8nKZ5V
Further company coverage: HEAC.NS
(([email protected];;))
May 29 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
CONSIDERING POTENTIAL INORGANIC RESTRUCTURING OF ITS OPERATIONS IN NAGPUR
CONSIDERING INCREASING ITS INTEREST IN HCG NCHRI ONCOLOGY LLP
EVALUATING GREENFIELD AND BROWNFIELD OPPORTUNITIES IN MADHYA PRADESH
Source text for Eikon: ID:nNSEzdsFS
Further company coverage: HEAC.NS
(([email protected];;))
May 29 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
CONSIDERING POTENTIAL INORGANIC RESTRUCTURING OF ITS OPERATIONS IN NAGPUR
CONSIDERING INCREASING ITS INTEREST IN HCG NCHRI ONCOLOGY LLP
EVALUATING GREENFIELD AND BROWNFIELD OPPORTUNITIES IN MADHYA PRADESH
Source text for Eikon: ID:nNSEzdsFS
Further company coverage: HEAC.NS
(([email protected];;))
May 25 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
INDIA'S HEALTHCARE GLOBAL ENTERPRISES MARCH-QUARTER CONSOL NET PROFIT 83.7 MILLION RUPEES VERSUS 59.9 MILLION RUPEES
HEALTHCARE GLOBAL ENTERPRISES MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 4.41 BILLION RUPEES VERSUS 3.64 BILLION RUPEES
Source text for Eikon: ID:nBSE9ff4wn
Further company coverage: HEAC.NS
(([email protected];))
May 25 (Reuters) - Healthcare Global Enterprises Ltd HEAC.NS:
INDIA'S HEALTHCARE GLOBAL ENTERPRISES MARCH-QUARTER CONSOL NET PROFIT 83.7 MILLION RUPEES VERSUS 59.9 MILLION RUPEES
HEALTHCARE GLOBAL ENTERPRISES MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 4.41 BILLION RUPEES VERSUS 3.64 BILLION RUPEES
Source text for Eikon: ID:nBSE9ff4wn
Further company coverage: HEAC.NS
(([email protected];))
More Small Cap Ideas
See similar 'Small' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does HealthcareGlobal do?
HealthCare Global Enterprises Ltd (HCG) is India's largest provider of cancer care with a network of comprehensive cancer centers. They also own fertility centers under the brand 'Milann', leading in specialist tertiary healthcare.
Who are the competitors of HealthcareGlobal?
HealthcareGlobal major competitors are Jupiter Life Line, Yatharth Hospital, Kovai Medical Center, Artemis MedicareServ, Indraprastha Medical, RainbowChildrenS Med, Dr Agarwals Eye Hsp. Market Cap of HealthcareGlobal is ₹9,093 Crs. While the median market cap of its peers are ₹6,385 Crs.
Is HealthcareGlobal financially stable compared to its competitors?
HealthcareGlobal seems to be less financially stable compared to its competitors. Altman Z score of HealthcareGlobal is 3.4 and is ranked 8 out of its 8 competitors.
Does HealthcareGlobal pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. HealthcareGlobal latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has HealthcareGlobal allocated its funds?
Companies resources are allocated to majorly productive assets like Plant & Machinery
How strong is HealthcareGlobal balance sheet?
Balance sheet of HealthcareGlobal is strong. But short term working capital might become an issue for this company.
Is the profitablity of HealthcareGlobal improving?
No, profit is decreasing. The profit of HealthcareGlobal is ₹21.32 Crs for TTM, ₹44.41 Crs for Mar 2025 and ₹48.16 Crs for Mar 2024.
Is the debt of HealthcareGlobal increasing or decreasing?
Yes, The net debt of HealthcareGlobal is increasing. Latest net debt of HealthcareGlobal is ₹369 Crs as of Mar-26. This is greater than Mar-25 when it was ₹310 Crs.
Is HealthcareGlobal stock expensive?
Yes, HealthcareGlobal is expensive. Latest PE of HealthcareGlobal is 667, while 3 year average PE is 150. Also latest EV/EBITDA of HealthcareGlobal is 20.5 while 3yr average is 18.46.
Has the share price of HealthcareGlobal grown faster than its competition?
HealthcareGlobal has given better returns compared to its competitors. HealthcareGlobal has grown at ~35.6% over the last 2yrs while peers have grown at a median rate of 20.6%
Is the promoter bullish about HealthcareGlobal?
Promoters seem to be bullish about the company. Latest quarter promoter holding is 64.21% and last quarter promoter holding is 63.77%.
Are mutual funds buying/selling HealthcareGlobal?
The mutual fund holding of HealthcareGlobal is increasing. The current mutual fund holding in HealthcareGlobal is 15.31% while previous quarter holding is 15.08%.